Department of Pharmacy Services, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA.
Department of Medicine, Division of Infectious Diseases, Oregon Health and Science University, 3181 SW Sam Jackson Park Road, Portland, OR 97239, USA.
Int J Antimicrob Agents. 2019 Nov;54(5):652-654. doi: 10.1016/j.ijantimicag.2019.08.007. Epub 2019 Aug 6.
Dalbavancin is a lipoglycopeptide antibiotic with unique weekly dosing active against Gram-positive organisms. This retrospective study included 37 patients receiving a mean of 2.7 weeks of dalbavancin. Nine patients (24%) were re-admitted to the hospital within 30 days. A total of 617 hospital days were saved, estimated to result in US$1 495 336 in savings and a mean cost avoidance of US$40 414 per patient. Dalbavancin provides a valuable antibiotic option that may minimise healthcare expenditure.
达巴万星是一种新型糖肽类抗生素，每周给药 1 次，活性覆盖革兰阳性菌。本回顾性研究纳入 37 例接受达巴万星治疗的患者，平均疗程为 2.7 周。9 例（24%）患者在 30 天内再次住院。共节省 617 个住院日，估计可节省 149.5336 万美元，平均每位患者可避免 40414 美元的费用。达巴万星提供了一种有价值的抗生素选择，可能会降低医疗保健支出。
